Skip to main content
Top
Published in: Rheumatology International 11/2012

01-11-2012 | Case Report

Juvenile systemic lupus erythematosus and dermatomyositis associated with urticarial vasculitis syndrome: a unique presentation

Authors: Patrícia A. Macêdo, Carolina B. Garcia, Monique K. Schmitz, Levi H. Jales, Rosa M. R. Pereira, Jozélio F. Carvalho

Published in: Rheumatology International | Issue 11/2012

Login to get access

Abstract

To report a case of triple association of juvenile systemic lupus erythematosus (SLE), juvenile dermatomyositis and urticarial vasculitis as well as a review of the relevant literature. A 12-year-old male patient diagnosed with overlap syndrome between SLE and juvenile dermatomyositis since 2004 evolved with erythematous plaques, which were compatible with an urticarial rash. Clinical, laboratory and histopathological findings indicated a diagnosis of urticarial vasculitis. The patient previously had a C1q deficiency. Using the established treatment with methylprednisolone (1 g/day for 3 days), increasing doses of deflazacort and introduction of a dapsone, as well as mycophenolate mofetil regimen, with the suspension of azathioprine resulted in complete resolution of skin lesions. Urticarial vasculitis can present in various diseases. In SLE, presentation of urticarial vasculitis in children is rarely found. The triple association of juvenile-onset SLE, juvenile dermatomyositis and urticarial vasculitis is unusual, and this is the first case described in literature.
Literature
1.
go back to reference McDuffie FC, Mitchell Sams W, Maldonado JE, Andreini PH, Conn DL, Samayoa EA (1973) Hypocomplementemia with cutaneous vasculitis and arthritis: possible immune complex syndrome. Mayo Clin Proc 48:340–348PubMed McDuffie FC, Mitchell Sams W, Maldonado JE, Andreini PH, Conn DL, Samayoa EA (1973) Hypocomplementemia with cutaneous vasculitis and arthritis: possible immune complex syndrome. Mayo Clin Proc 48:340–348PubMed
2.
go back to reference Mehregan DR, Hall MJ, Gibson LE (1992) Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 26:441–448PubMedCrossRef Mehregan DR, Hall MJ, Gibson LE (1992) Urticarial vasculitis: a histopathologic and clinical review of 72 cases. J Am Acad Dermatol 26:441–448PubMedCrossRef
3.
go back to reference Davis MD, Brewer JD (2004) Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 24(2):183–213 MayPubMedCrossRef Davis MD, Brewer JD (2004) Urticarial vasculitis and hypocomplementemic urticarial vasculitis syndrome. Immunol Allergy Clin North Am 24(2):183–213 MayPubMedCrossRef
4.
go back to reference Dincy CV, George R, Jacob M, Mathai E, Pulimood S, Eapen EP (2008) Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India. Eur Acad Dermatol Venereol 22(7):789–794 JulCrossRef Dincy CV, George R, Jacob M, Mathai E, Pulimood S, Eapen EP (2008) Clinicopathologic profile of normocomplementemic and hypocomplementemic urticarial vasculitis: a study from South India. Eur Acad Dermatol Venereol 22(7):789–794 JulCrossRef
5.
go back to reference Yamazaki-Nakashimada MA, Duran-McKinster C, Ramírez-Vargas N, Hernandez-Bautista V (2009) Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child. Pediatr Dermatol 26(4):445–447 Jul-AugPubMedCrossRef Yamazaki-Nakashimada MA, Duran-McKinster C, Ramírez-Vargas N, Hernandez-Bautista V (2009) Intravenous immunoglobulin therapy for hypocomplementemic urticarial vasculitis associated with systemic lupus erythematosus in a child. Pediatr Dermatol 26(4):445–447 Jul-AugPubMedCrossRef
6.
go back to reference Venzor J, Lee WL, Huston DP (2002) Urticarial vasculitis. Clin Rev Allergy Immunol 23(2):201–216 OctPubMedCrossRef Venzor J, Lee WL, Huston DP (2002) Urticarial vasculitis. Clin Rev Allergy Immunol 23(2):201–216 OctPubMedCrossRef
7.
go back to reference Lee JS, Loh TH, Seow SC, Tan SH (2007) Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis. J Am Acad Dermatol 56(6):994–1005 JunPubMedCrossRef Lee JS, Loh TH, Seow SC, Tan SH (2007) Prolonged urticaria with purpura: the spectrum of clinical and histopathologic features in a prospective series of 22 patients exhibiting the clinical features of urticarial vasculitis. J Am Acad Dermatol 56(6):994–1005 JunPubMedCrossRef
8.
go back to reference Tosoni C, Lodi-Rizzini F, Cinquini M, Pasolini G, Venturini M, Sinico RA, Calzavara-Pinton P (2009) A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients. Clin Exp Dermatol 34(2):166–170 MarPubMedCrossRef Tosoni C, Lodi-Rizzini F, Cinquini M, Pasolini G, Venturini M, Sinico RA, Calzavara-Pinton P (2009) A reassessment of diagnostic criteria and treatment of idiopathic urticarial vasculitis: a retrospective study of 47 patients. Clin Exp Dermatol 34(2):166–170 MarPubMedCrossRef
9.
go back to reference Alexander EL, Provost TT (1983) Cutaneous manifestations of primary Sjogren’s syndrome: a reflection of vasculitis and association with anti-Ro (SSA) antibodies. J Invest Dermatol 80:386–391PubMedCrossRef Alexander EL, Provost TT (1983) Cutaneous manifestations of primary Sjogren’s syndrome: a reflection of vasculitis and association with anti-Ro (SSA) antibodies. J Invest Dermatol 80:386–391PubMedCrossRef
10.
go back to reference Amano H, Furuhata N, Tamura N, Tokano Y, Takasaki Y (2008) Hypocomplementemic urticarial vasculitis with Jaccoud’s arthropathy and valvular heart disease: case report and review of the literature. Lupus 17(9):837–841 SepPubMedCrossRef Amano H, Furuhata N, Tamura N, Tokano Y, Takasaki Y (2008) Hypocomplementemic urticarial vasculitis with Jaccoud’s arthropathy and valvular heart disease: case report and review of the literature. Lupus 17(9):837–841 SepPubMedCrossRef
11.
go back to reference Chew GY, Gatenby PA (2007) Inflammatory myositis complicating hypocomplementemic urticarial vasculitis despite on-going immunosuppression. Clin Rheumatol 26(8):1370–1372 AugPubMedCrossRef Chew GY, Gatenby PA (2007) Inflammatory myositis complicating hypocomplementemic urticarial vasculitis despite on-going immunosuppression. Clin Rheumatol 26(8):1370–1372 AugPubMedCrossRef
12.
go back to reference Martini A, Ravelli A, Albani S, De Benedetti F, Massa M, Wisnieski JJ (1994) Hypocomplementemic urticarial vasculitis syndrome with severe manifestations. J Pediatr 124:742–744PubMedCrossRef Martini A, Ravelli A, Albani S, De Benedetti F, Massa M, Wisnieski JJ (1994) Hypocomplementemic urticarial vasculitis syndrome with severe manifestations. J Pediatr 124:742–744PubMedCrossRef
13.
go back to reference Al BMS, Riyami Æ JK, Al Kaabi Æ EM, Elagib HS, El Khatim Æ NJY (2003) Woodhouse subclinical pulmonary haemorrhage causing a restrictive lung defect in three siblings with a unique urticarial vasculitis syndrome. Clin Rheumatol 22:309–313 Al BMS, Riyami Æ JK, Al Kaabi Æ EM, Elagib HS, El Khatim Æ NJY (2003) Woodhouse subclinical pulmonary haemorrhage causing a restrictive lung defect in three siblings with a unique urticarial vasculitis syndrome. Clin Rheumatol 22:309–313
14.
15.
go back to reference Forston JS, Zone JJ, Hammond ME, Groggel GC (1986) Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone. J Am Acad Dermatol 15:1137–1142CrossRef Forston JS, Zone JJ, Hammond ME, Groggel GC (1986) Hypocomplementemic urticarial vasculitis syndrome responsive to dapsone. J Am Acad Dermatol 15:1137–1142CrossRef
16.
go back to reference Mukhtyar C, Misbah S, Wilkinson J, Wordsworth P (2009) Refractory urticarial vasculitis responsive to anti-B-cell therapy. Br J Dermatol 160(2):470–472 FebPubMedCrossRef Mukhtyar C, Misbah S, Wilkinson J, Wordsworth P (2009) Refractory urticarial vasculitis responsive to anti-B-cell therapy. Br J Dermatol 160(2):470–472 FebPubMedCrossRef
Metadata
Title
Juvenile systemic lupus erythematosus and dermatomyositis associated with urticarial vasculitis syndrome: a unique presentation
Authors
Patrícia A. Macêdo
Carolina B. Garcia
Monique K. Schmitz
Levi H. Jales
Rosa M. R. Pereira
Jozélio F. Carvalho
Publication date
01-11-2012
Publisher
Springer-Verlag
Published in
Rheumatology International / Issue 11/2012
Print ISSN: 0172-8172
Electronic ISSN: 1437-160X
DOI
https://doi.org/10.1007/s00296-010-1484-4

Other articles of this Issue 11/2012

Rheumatology International 11/2012 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.